Get the Stockscreener App
9.0174
1.69%
0.1474
Teladoc Health Inc stock is traded at $9.0174, with a volume of 2.94M.
It is up +1.69% in the last 24 hours and down -0.22% over the past month.
See More
Previous Close:
$8.87
Open:
$8.88
24h Volume:
2.94M
Relative Volume:
0.55
Market Cap:
$1.58B
Revenue:
$2.61B
Net Income/Loss:
$-1.01B
P/E Ratio:
-0.3657
EPS:
-24.66
Net Cash Flow:
$195.87M
1W Performance:
+1.12%
1M Performance:
-0.22%
6M Performance:
-29.42%
1Y Performance:
-48.10%
1-Day Range:
$8.635
$9.17
1-Week Range:
$8.31
$9.95
52-Week Range:
$6.76
$22.54
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
2 MANHATTANVILLE ROAD, PURCHASE, NY
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit - Yahoo Finance
Every Teladoc Investor Should Keep an Eye on This Number - Yahoo Finance
Teladoc Health (NYSE:TDOC) Stock Price Down 7.3%Here's What Happened - MarketBeat
Leerink Partnrs Expects Weaker Earnings for Teladoc Health - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Simply Wall St
Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says - MarketBeat
Leerink Partnrs Weighs in on Teladoc Health Q1 Earnings - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Q3 2024 Earnings Call Transcript - Insider Monkey
TDOC (Teladoc Health) Cash From Discontinued Investing Acti - GuruFocus.com
Earnings call: Teladoc Health reports mixed Q3 results, plans for 2025 By Investing.com - Investing.com South Africa
Earnings call: Teladoc Health reports mixed Q3 results, plans for 2025 - Investing.com Australia
'3Q print less bad than feared', Citi lifts Teladoc stock PT to $11 - Investing.com
Former Teladoc Executive and Healthcare Operations Veteran Jennifer Close Joins Curai Health as Chief Operating Officer - PR Newswire
Teladoc Health (NYSE:TDOC) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
December 13th Options Now Available For Teladoc Health (TDOC) - Nasdaq
Teladoc stock rises 7% as Q3 earnings, forecast top Street estimates - MSN
Teladoc stock soars 11% after earnings beat By Investing.com - Investing.com South Africa
Teladoc (TDOC) PT Raised to $11 at Citi - StreetInsider.com
Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navi - GuruFocus.com
Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navigating Challenges and Strategic ... - Yahoo Finance
Teladoc Health Reports Q3 2024 Financial Results - TipRanks
Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Teladoc (NYSE:TDOC) Surprises With Q3 Sales, Stock Jumps 10.3% - Yahoo Finance
Teladoc Health Q3 Earnings: Revenue Beat, EPS Beat, Shares Jump 10% - Benzinga
Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Teladoc holds $9 target with in line rating post Q3 results - Investing.com
Teladoc: Q3 Earnings Snapshot - San Francisco Chronicle
Teladoc stock rises 7% as Q3 earnings, forecast top Street estimates (NYSE:TDOC) - Seeking Alpha
Teladoc Health Reports Third Quarter 2024 Results - StockTitan
Teladoc Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
How the (TDOC) price action is used to our Advantage - Stock Traders Daily
Teladoc Health Q3 Earnings Preview: Investors brace for BetterHealth, strategic updates - MSN
Teladoc (TDOC) To Report Earnings Tomorrow: Here Is What To Expect By Stock Story - Investing.com Canada
U.S. Digital Therapeutics Market Business Growth, Development - openPR
Teladoc (TDOC) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Remote Patient Monitoring Market Types and Applications, - openPR
Exploring Analyst Estimates for Teladoc (TDOC) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance
TDOC (Teladoc Health) Pre-Tax Income : $-998 Mil (TTM As of Jun. 2024) - GuruFocus.com
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat - MSN
Assenagon Asset Management S.A. Takes Position in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
TDOC (Teladoc Health) Change In Working Capital : $-39 Mil (TTM As of Jun. 2024) - GuruFocus.com
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment - AOL
Teladoc (TDOC) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Teladoc Health's SWOT analysis: stock faces challenges amid leadership change - Investing.com
Is Teladoc Health (NYSE:TDOC) A Risky Investment? - Simply Wall St
Teledermatology Market Set to Exceed $38.9 Billion by 2032; Teladoc Health Unveils All-in-One Digital Care ... - WhaTech
Teladoc Health (TDOC) Scheduled to Post Earnings on Wednesday - MarketBeat
Is Marqeta Inc. (MQ) the Best US Stock to Buy Under $10? - Yahoo Finance
Is Teladoc Health Inc. (TDOC) the Best US Stock to Buy Under $10? - Insider Monkey
Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages - Defense World
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):